Close Menu

NEW YORK – Bionano Genomics has filed regulatory documents for a public offering of up to $30 million of its common stock and warrants to purchase its common stock.

The genome mapping firm also amended its loan agreement with Innovatus Life Science Lending Fund on March 6 and will make prepayments on the principal totaling $5 million and pay fees of $300,000. Moreover, Bionano registered a resale of approximately 1.1. million shares of its common stock on behalf of Innovatus.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.